EUVIMEDEUVIMED entdecken
Crossref

Metabolic reallocation in spinal cord oligodendrocytes drives chronic pain in mice through neuronal Aβ 42 production

Yannick Fotio iD, Saeed Al Masri iD, Zechuan Shi iD, Johnny Le iD, Sudeshna Das, Varvara I Rubtsova, Alex Mabou Tagne iD, Cholsoon Jang iD, Vivek Swarup iD, Daniele Piomelli iD

Science Translational Medicine · 2026

DOI: 10.1126/scitranslmed.aea8738 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Translational Medicine, 2026. Verfasst von Yannick Fotio und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy and Neurobiology, University of California Irvine, Irvine, CA 92697, USA. Hauptthemen laut MEDLINE: Spinal Cord, Oligodendroglia, Amyloid beta-Peptides, Chronic Pain. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent evidence implicates a metabolic switch in afferent spinal circuits as a key driver of the transition from acute pain– to chronic pain–related behaviors in mice after tissue injury, yet the cellular substrates and functional consequences remain incompletely defined. Using a combination of pharmacological and genetic approaches, we investigated whether metabolic reprogramming in spinal cord cell populations constitutes a causal mechanism linking peripheral injury to the progression to pain chronicity. After peripheral injury induced by a hindpaw formalin injection in mice, single-nucleus RNA sequencing (snRNA-seq) revealed that spinal oligodendrocytes down-regulated transcripts for myelin protein synthesis and up-regulated transcripts important for lipid biosynthesis. Comparative lipidomics showed that this resource reallocation after peripheral injury was associated with disrupted spinal myelin composition. Moreover, axonal integrity was compromised, causing neuronal accumulation of amyloid precursor protein, enhanced β-site amyloid precursor protein–cleaving enzyme 1 (BACE1) expression, and increased insoluble amyloid-β 42 (Aβ 42 ) during a critical temporal window for the transition to pain chronicity. Blocking Aβ 42 production by BACE1 inhibition or clearing Aβ 42 by intrathecal 4G8 monoclonal antibody injection prevented the emergence of persistent pain after hindpaw formalin injection. Oligodendrocyte-specific deletion of N -acylethanolamine acid amidase, a key regulator of cell metabolism and pain, prevented Aβ 42 release and chronic pain development induced by formalin injection or sciatic nerve ligation. These findings uncover an unexpected mechanistic link between chronic pain and amyloid pathology and identify the NAAA→Aβ 42 pathway as a target for disease-modifying intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spinal CordOligodendrogliaAmyloid beta-PeptidesChronic PainNeuronsPeptide FragmentsAnimalsAmyloid Precursor Protein SecretasesMaleMyelin SheathMice, Inbred C57BLAspartic Acid EndopeptidasesMiceAxons

Substanzen

Amyloid beta-PeptidesAmyloid Precursor Protein Secretasesamyloid beta-protein (1-42)Peptide FragmentsAspartic Acid EndopeptidasesBace1 protein, mouse

Autor:innen und Institutionen

  • Department of Anatomy and Neurobiology, University of California Irvine, Irvine, CA 92697, USA.
  • Department of Pharmaceutical Sciences, University of California Irvine, Irvine, CA 92697 USA.
  • Department of Neurobiology and Behavior, University of California Irvine, Irvine, CA 92697, USA.
  • Department of Biological Chemistry, University of California Irvine, Irvine, CA 92697, USA.

ORCID-Profile: Yannick Fotio, Saeed Al Masri, Zechuan Shi, Johnny Le, Alex Mabou Tagne, Cholsoon Jang, Vivek Swarup, Daniele Piomelli

Förderung

  • National Institutes of Health

Zitieren

APA

Fotio, Y., Al Masri, S., Shi, Z., Le, J., Das, S., Rubtsova, V. I., Mabou Tagne, A., Jang, C., Swarup, V., & Piomelli, D. (2026). Metabolic reallocation in spinal cord oligodendrocytes drives chronic pain in mice through neuronal Aβ 42 production. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.aea8738

Vancouver

Fotio Y, Al Masri S, Shi Z, Le J, Das S, Rubtsova VI, et al. Metabolic reallocation in spinal cord oligodendrocytes drives chronic pain in mice through neuronal Aβ 42 production. Science Translational Medicine. 2026. doi:10.1126/scitranslmed.aea8738

BibTeX
@article{Fotio2026,
  author = {Fotio, Yannick and Al Masri, Saeed and Shi, Zechuan and Le, Johnny and Das, Sudeshna and Rubtsova, Varvara I and Mabou Tagne, Alex and Jang, Cholsoon and Swarup, Vivek and Piomelli, Daniele},
  title = {Metabolic reallocation in spinal cord oligodendrocytes drives chronic pain in mice through neuronal Aβ 42 production},
  journal = {Science Translational Medicine},
  year = {2026},
  doi = {10.1126/scitranslmed.aea8738}
}
Kostenlos starten →